Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30
Published August 9, 2017 · Recall initiated: July 28, 2017
Summary
FDA records drug Class II recall D-1057-2017, published August 9, 2017 and initiated July 28, 2017. Recalling firm: PD-Rx Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 100 bottles; Lot: Lot: A17F55 Exp. 06/30/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification: out of specification for tablet weight.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Distributor
- Nationwide
- Lot
- Lot: A17F55 Exp. 06/30/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OKJanuary 1, 2025
- FDASimvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx PharmaceuticalsMay 10, 2023
- FDAGlimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx PharmaceuticalsMay 10, 2023
- FDAMontelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By:May 10, 2023
- FDAFamotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA,August 9, 2017
- FDASteamers in 5 Clams in Butter & Garlic Sauce, Goose Point brand. Product is packaged in a plastic tray withAugust 9, 2017
Questions about this recall
Was Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30 recalled?
Yes. FDA published recall D-1057-2017 on August 9, 2017. Reported hazard: Failed Tablet/Capsule Specification: out of specification for tablet weight.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail